Evidence map›Paper›PMID 40302723›Full record

ArticleOpen forum infectious diseases2025

Distinct Clinical Features of Extrapulmonary and Disseminated Tuberculosis in HIV- and Non-HIV-Associated Immunosuppression: A Retrospective Cohort Study.

Brenda Aceves-Sánchez, Sandra Rajme-López, Bernardo A Martínez-Guerra, Hector Rivera-Villegas, Carla M Román-Montes, Karla M Tamez-Torres, Luz E González-Vázquez, Sebastián Guadarrama-Torres, Oswaldo Lazcano-Delgadillo, Rafael Nares-López and 7 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Pathogens (Basel, Switzerland) · 2026
    Article
  3. Observational
  4. Review
  5. Article
  6. Infectious disease reports · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Brenda Aceves-SánchezDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0001-5256-3858
Sandra Rajme-LópezDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0001-7809-9619
Bernardo A Martínez-GuerraDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-5191-2179
Hector Rivera-VillegasDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0009-0009-9735-3892
Carla M Román-MontesDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-2509-618X
Karla M Tamez-TorresDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Luz E González-VázquezDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Sebastián Guadarrama-TorresDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0009-0009-8613-9428
Oswaldo Lazcano-DelgadilloDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Rafael Nares-LópezDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0002-9668-2354
Zurisadai Segura-OrtízDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Karen M Tepo-PonceDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
María F González-LaraDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0003-0292-3442
Bárbara Chávez-MazariLaboratory of Clinical Microbiology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Miriam Bobadilla-Del-ValleLaboratory of Clinical Microbiology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.ORCID https://orcid.org/0000-0003-1184-827X
José Sifuentes-OsornioGeneral Direction, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
Alfredo Ponce-de-LeónDepartment of Infectious Diseases, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is scarce information regarding the clinical differences between extrapulmonary and disseminated tuberculosis (TB) in patients with different types of immunosuppression. We aimed to compare the clinical characteristics and outcomes of extrapulmonary and disseminated TB in patients with non-human immunodeficiency virus (HIV)-associated and HIV-associated immunocompromise. Methods: In this retrospective cohort study, we included immunocompromised adults with extrapulmonary or disseminated TB in a referral center in Mexico City from January 2000 to December 2023. We compared clinical characteristics, treatments, and death. Multivariate logistic regression analysis for death-related characteristics and Kaplan-Meier survival estimates were performed. Results: We included 180 patients: 81 with non-HIV-associated and 99 with HIV-associated immunosuppression (CD4 Conclusions: Disseminated TB was more frequent in the HIV group. Factors associated with mortality differed, highlighting CNS involvement in the non-HIV group and malignancy in the HIV group.

Indexed as

disseminated tuberculosisextrapulmonary tuberculosisHIVimmunocompromisetuberculosis

Identifiers

PMID40302723
PMCPMC12039804

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.